MEC Practice Academy 11.19
|Articles|October 10, 2011

Medical Economics, Digital Edition, October 10th, 2011

Related to this article

Sethu Reddy: ©Sethu Reddy
Prior authorization, step therapy and shifting coverage rules keep patients from obesity drugs with proven benefits, an endocrinologist argues — and the long-term savings make the case for broader access.